| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 4.57 | 0.04 (+0.88%) | 2.56 - 6.65 | 87.1 thousand (Below Avg) |
Market data as of 12:58PM 06/19/13. Quotes are delayed by at least 15 min.
| Open | 4.51 |
|---|---|
| Previous Close | 4.53 |
| Day's Range | 4.44 - 4.65 |
| Market Cap | 72.2M |
| Avg Volume (10 Day) | 210.1K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -3.1 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Neutral |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Neutral |
| Borrows within reasonable limits? | Neutral |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Fail |
| Has sufficient liquidity? | Pass |
No news headlines available for ALXA
| ALXA | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | -53.62% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | -- | |
| LT Debt/Equity | -- | |
| Earnings Yield | -- | |
| Price/Sales | 24.55 |
| Company | Last | Change |
|---|---|---|
| Biodel Inc | 4.30 | -9.66% |
| Apricus Biosciences Inc | 2.53 | -1.60% |
| DURECT Corp | 0.83 | -0.23% |
| Cumberland Pharmaceuticals Inc | 5.04 | 0.00% |
| NovaBay Pharmaceuticals Inc | 1.34 | 0.00% |
Data is delayed by at least 15 min.